Hantavirus interferon regulation and virulence determinants

Virus Research

Volumn 187, Issue , 2014, Pages 65-71

  Mackow, Erich R ^a   Dalrymple, Nadine A ^a   Cimica, Velasco ^a   Matthys, Valery ^a   Gorbunova, Elena ^a   Gavrilovskaya, Irina ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Endothelial cell; Hantavirus; Interferon; Pathogenesis; Permeability; TBK1

Indexed keywords

BETA INTERFERON; GN PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON STIMULATED GENE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS PROTEIN; CADHERIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON REGULATORY FACTOR; LEUKOCYTE ANTIGEN; MTOR PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TARGET OF RAPAMYCIN KINASE; TBK1 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HANTAVIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS VIRULENCE; ANOXIA; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CAPILLARY; CAPILLARY PERMEABILITY; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; HANTAVIRUS INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; VASCULAR ENDOTHELIUM; VIROLOGY; VIRULENCE;

HANTAVIRUS; PROSPECT HILL VIRUS;

ANOXIA; ANTIGENS, CD; CADHERINS; CAPILLARIES; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HANTAVIRUS; HANTAVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERFERON REGULATORY FACTORS; INTERFERON-BETA; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRULENCE; VIRUS REPLICATION;

EID: 84902254470     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.12.041     Document Type: Article

References (95)

1. Alff P.J., Gavrilovskaya I.N., Gorbunova E., Endriss K., Chong Y., Geimonen E., Sen N., Reich N.C., Mackow E.R. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 2006, 80:9676-9686.
2. Alff P.J., Sen N., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J. Virol. 2008, 82:9115-9122.
3. Alitalo K. The lymphatic vasculature in disease. Nat. Med. 2011, 17:1371-1380.
4. Berger M.M., Hesse C., Dehnert C., Siedler H., Kleinbongard P., Bardenheuer H.J., Kelm M., Bartsch P., Haefeli W.E. Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 2005, 172:763-767.
5. Birks J.W., Klassen L.W., Gurney C.W. Hypoxia-induced thrombocytopenia in mice. J. Lab. Clin. Med. 1975, 86:230-238.
6. Borges E., Jan Y., Ruoslahti E. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J. Biol. Chem. 2000, 275:39867-39873.
7. Bustamante E.A., Levy H., Simpson S.Q. Pleural fluid characteristics in hantavirus pulmonary syndrome. Chest 1997, 112:1133-1136.
8. Byzova T.V., Goldman C.K., Pampori N., Thomas K.A., Bett A., Shattil S.J., Plow E.F. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 2000, 6:851-860.
9. Charoenthongtrakul S., Gao L., Parvatiyar K., Lee D., Harhaj E.W. RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS ONE 2013, 8:e53717.
10. Christou H., Yoshida A., Arthur V., Morita T., Kourembanas S. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 1998, 18:768-776.
11. Coller B.S., Shattil S.J. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008, 112:3011-3025.
12. Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., Lampugnani M.G., Martin-Padura I., Stoppacciaro A., Ruco L., McDonald D.M., Ward P.A., Dejana E. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9815-9820.
13. Corada M., Zanetta L., Orsenigo F., Breviario F., Lampugnani M.G., Bernasconi S., Liao F., Hicklin D.J., Bohlen P., Dejana E. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 2002, 100:905-911.
14. Daffis S., Suthar M.S., Szretter K.J., Gale M., Diamond M.S. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog. 2009, 5:e1000607.
15. Dehler M., Zessin E., Bartsch P., Mairbaurl H. Hypoxia causes permeability oedema in the constant-pressure perfused rat lung. Eur. Respir. J. 2006, 27:600-606.
16. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 2008, 121:2115-2122.
17. Delhase M., Kim S.Y., Lee H., Naiki-Ito A., Chen Y., Ahn E.R., Murata K., Kim S.J., Lautsch N., Kobayashi K.S., Shirai T., Karin M., Nakanishi M. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc. Natl. Acad. Sci. U. S. A. 2011, 109:E177-E218.
18. Duchin J.S., Koster F.T., Peters C.J., Simpson G.L., Tempest B., Zaki S.R., Ksiazek T.G., Rollin P.E., Nichol S., Umland E.T., Moolenaar R.L., Reef S.E., Nolte K.B., Gallaher M.M., Butler J.C., Breiman R.F., Group H.S. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N. Engl. J. Med. 1994, 330:949-955. (See comments).
19. Dvorak H.F. Discovery of vascular permeability factor (VPF). Exp. Cell Res. 2006, 312:522-526.
20. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995, 146:1029-1039.
21. Enria D., Padula P., Segura E.L., Pini N., Edelstein A., Posse C.R., Weissenbacher M.C. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (Mex.) 1996, 56:709-711.
22. Farmer P.J., Bernier S.G., Lepage A., Guillemette G., Regoli D., Sirois P. Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L732-L738.
23. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16:4604-4613.
24. Gavard J. Breaking the VE-cadherin bonds. FEBS Lett. 2009, 583:1-6.
25. Gavard J., Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 2006, 8:1223-1234.
26. Gavard J., Patel V., Gutkind J.S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 2008, 14:25-36.
27. Gavrilovskaya I., Gorbunova E., Koster F., Mackow E. Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv. Virol. 2012, 674360.
28. Gavrilovskaya I., Gorbunova E., Matthys V., Dalrymple N., Mackow E. The role of the endothelium in HPS pathogenesis and potential therapeutic approaches. Adv. Virol. 2012, 467059.
29. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 1999, 73:3951-3959.
30. Gavrilovskaya I.N., Gorbunova E.E., Mackow E.R. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J. Virol. 2010, 84:4832-4839.
31. Gavrilovskaya I.N., Gorbunova E.E., Mackow E.R. Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive. J. Virol. 2012, 86:8765-8772.
32. Gavrilovskaya I.N., Gorbunova E.E., Mackow E.R. Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway. J. Virol. 2013, 87:12999-13008.
33. Gavrilovskaya I.N., Gorbunova E.E., Mackow N.A., Mackow E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 2008, 82:5797-5806.
34. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. beta3-Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7074-7079.
35. Geimonen E., Neff S., Raymond T., Kocer S.S., Gavrilovskaya I.N., Mackow E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13837-13842.
36. Gorbunova E., Gavrilovskaya I.N., Mackow E.R. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J. Virol. 2010, 84:7405-7411.
37. Gorbunova E.E., Gavrilovskaya I.N., Mackow E.R. Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells. Antiviral Res. 2013, 99:108-112.
38. Gorbunova E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. VEGFR2 and Src kinase inhibitors suppress ANDV induced endothelial cell permeability. J. Virol. 2011, 85:2296-2303.
39. Hacker H., Tseng P.H., Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 2011, 11:457-468.
40. Hagendoorn J., Padera T.P., Kashiwagi S., Isaka N., Noda F., Lin M.I., Huang P.L., Sessa W.C., Fukumura D., Jain R.K. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ. Res. 2004, 95:204-209.
41. Hammerbeck C.D., Hooper J.W. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J. Virol. 2011, 85:9929-9944.
42. Hanaoka M., Droma Y., Naramoto A., Honda T., Kobayashi T., Kubo K. Vascular endothelial growth factor in patients with high-altitude pulmonary edema. J. Appl. Physiol. 2003, 94:1836-1840.
43. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 2007, 282:15325-15329.
44. Hodivala-Dilke K.M., McHugh K.P., Tsakiris D.A., Rayburn H., Crowley D., Ullman-Cullere M., Ross F.P., Coller B.S., Teitelbaum S., Hynes R.O. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 1999, 103:229-238.
45. Hopkins S.R., Garg J., Bolar D.S., Balouch J., Levin D.L. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 2005, 171:83-87.
46. Irigoyen M., Anso E., Martinez E., Garayoa M., Martinez-Irujo J.J., Rouzaut A. Hypoxia alters the adhesive properties of lymphatic endothelial cells. Biochim. Biophys. Acta 2007, 1773:880-890.
47. Kilpatrick E.D., Terajima M., Koster F.T., Catalina M.D., Cruz J., Ennis F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 2004, 172:3297-3304.
48. Kim D.D., Kleinman D.M., Kanetaka T., Gerritsen M.E., Nivaggioli T., Weber D., Duran W.N. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. Microcirculation 2009, 17:128-136.
49. Kim K.S., Rajagopal V., Gonsalves C., Johnson C., Kalra V.K. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J. Immunol. 2006, 177:7211-7224.
50. Knox A.J., Corbett L., Stocks J., Holland E., Zhu Y.M., Pang L. Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J. 2001, 15:2480-2488.
51. Koster F., Mackow E. Pathogenesis of the hantavirus pulmonary syndrome. Future Virol. 2012, 7:41-51.
52. Kulshreshtha R., Davuluri R.V., Calin G.A., Ivan M. A microRNA component of the hypoxic response. Cell Death Differ. 2008, 15:667-671.
53. Lahdevirta J., Enger E., Hunderi O.H., Traavik T., Lee H.W. Hantaan virus is related to hemorrhagic fever with renal syndrome in Norway. Lancet 1982, 2:606.
54. Land S.C., Tee A.R. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J. Biol. Chem. 2007, 282:20534-20543.
55. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
56. Lazear H.M., Lancaster A., Wilkins C., Suthar M.S., Huang A., Vick S.C., Clepper L., Thackray L., Brassil M.M., Virgin H.W., Nikolich-Zugich J., Moses A.V., Gale M., Fruh K., Diamond M.S. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013, 9:e1003118.
57. Lee H.W. Hemorrhagic fever with renal syndrome (HFRS). Scand. J. Infect. Dis. Suppl. 1982, 36:82-85.
58. Lee H.W., Baek L.J., Johnson K.M. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J. Infect. Dis. 1982, 146:638-644.
59. Liesmaa I., Leskinen H.K., Kokkonen J.O., Ruskoaho H., Kovanen P.T., Lindstedt K.A. Hypoxia-induced expression of bradykinin type-2 receptors in endothelial cells triggers NO production, cell migration, and angiogenesis. J. Cell. Physiol. 2009, 221:359-366.
60. Lopez N., Padula P., Rossi C., Lazaro M.E., Franze-Fernandez M.T. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220:223-226.
61. Matthys V., Cimica V., Dalrymple N., Glennon N.B., Bianco C., Mackow E.R. Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1 directed IFNb transcription by blocking IRF3 phosphorylation. J. Virol. 2013, 88(4). Epub Jan 3, accession Number 24390324; ISSN 1098-5514.
62. Matthys V., Gorbunova E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. The C-terminal 42 residues of the TULV Gn protein regulate interferon induction. J. Virol. 2011, 85:4752-4760.
63. Matthys V., Mackow E.R. Hantavirus regulation of type I interferon responses. Adv. Virol. 2012, 524024.
64. Miao R.Q., Fontana J., Fulton D., Lin M.I., Harrison K.D., Sessa W.C. Dominant-negative Hsp90 reduces VEGF-stimulated nitric oxide release and migration in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:105-111.
65. Mori M., Rothman A.L., Kurane I., Montoya J.M., Nolte K.B., Norman J.E., Waite D.C., Koster F.T., Ennis F.A. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J. Infect. Dis. 1999, 179:295-302.
66. Nawroth R., Poell G., Ranft A., Kloep S., Samulowitz U., Fachinger G., Golding M., Shima D.T., Deutsch U., Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 2002, 21:4885-4895.
67. Nichol S.T., Spiropoulou C.F., Morzunov S., Rollin P.E., Ksiazek T.G., Feldmann H., Sanchez A., Childs J., Zaki S., Peters C.J. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262:914-917. (See comments).
68. Nolte K.B., Feddersen R.M., Foucar K., Zaki S.R., Koster F.T., Madar D., Merlin T.L., McFeeley P.J., Umland E.T., Zumwalt R.E. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 1995, 26:110-120.
69. Plyusnin A., Vapalahti O., Lankinen H., Lehvaslaiho H., Apekina N., Myasnikov Y., Kallio-Kokko H., Henttonen H., Lundkvist A., Brummer-Korvenkontio M., et al. Tula virus: a newly detected hantavirus carried by European common voles. J. Virol. 1994, 68:7833-7839.
70. Raymond T., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1163-1168.
71. Reynolds L.E., Wyder L., Lively J.C., Taverna D., Robinson S.D., Huang X., Sheppard D., Hynes R.O., Hodivala-Dilke K.M. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 2002, 8:27-34.
72. Robinson S.D., Reynolds L.E., Wyder L., Hicklin D.J., Hodivala-Dilke K.M. Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2108-2114.
73. Ruvinsky I., Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 2006, 31:342-348.
74. Scherrer U., Rexhaj E., Jayet P.Y., Allemann Y., Sartori C. New insights in the pathogenesis of high-altitude pulmonary edema. Prog. Cardiovasc. Dis. 2010, 52:485-492.
75. Schmaljohn C. Bunyaviridae and their replication. Virology 2001, 1581-1602. Lipppincott-Raven, Philadelphia. Fields (Ed.).
76. Schraufnagel D.E., Agaram N.P., Faruqui A., Jain S., Jain L., Ridge K.M., Sznajder J.I. Pulmonary lymphatics and edema accumulation after brief lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L891-L897.
77. Seth R.B., Sun L., Chen Z.J. Antiviral innate immunity pathways. Cell Res. 2006, 16:141-147.
78. Shrivastava-Ranjan P., Rollin P.E., Spiropoulou C.F. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 2010, 84:11227-11234.
79. Spiropoulou C.F., Albarino C.G., Ksiazek T.G., Rollin P.E. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol. 2007, 81:2769-2776.
80. Taylor S.L., Wahl-Jensen V., Copeland A.M., Jahrling P.B., Schmaljohn C.S. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog. 2013, 9:e1003470.
81. Terajima M., Hendershot J.D., Kariwa H., Koster F.T., Hjelle B., Goade D., DeFronzo M.C., Ennis F.A. High levels of viremia in patients with the Hantavirus pulmonary syndrome. J. Infect. Dis. 1999, 180:2030-2034.
82. Thuringer D., Maulon L., Frelin C. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells. J. Biol. Chem. 2002, 277:2028-2032.
83. Tu D., Zhu Z., Zhou A.Y., Yun C.H., Lee K.E., Toms A.V., Li Y., Dunn G.P., Chan E., Thai T., Yang S., Ficarro S.B., Marto J.A., Jeon H., Hahn W.C., Barbie D.A., Eck M.J. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 2013, 3:747-758.
84. Vaheri A., Strandin T., Hepojoki J., Sironen T., Henttonen H., Makela S., Mustonen J. Uncovering the mysteries of hantavirus infections. Nat. Rev. Microbiol. 2013, 11:539-550.
85. Voelkel N.F. High-altitude pulmonary edema. N. Engl. J. Med. 2002, 346:1606-1607.
86. Wallez Y., Vilgrain I., Huber P. Angiogenesis: the VE-cadherin switch. Trends Cardiovasc. Med. 2006, 16:55-59.
87. Wolff N.C., Vega-Rubin-de-Celis S., Xie X.J., Castrillon D.H., Kabbani W., Brugarolas J. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia. Mol. Cell. Biol. 2011, 31:1870-1884.
88. Xue Q., Nagy J.A., Manseau E.J., Phung T.L., Dvorak H.F., Benjamin L.E. Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1172-1178.
89. Yanagihara R., Daum C.A., Lee P.W., Baek L.J., Amyx H.L., Gajdusek D.C., Gibbs C.J. Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA. Trans. R. Soc. Trop. Med. Hyg. 1987, 81:42-45.
90. Yanagihara R., Silverman D.J. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol 1990, 111:281-286.
91. Yoneyama M., Fujita T. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev. 2007, 18:545-551.
92. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
93. Zaki S., Greer P., Coffield L., Goldsmith C., Nolte K., Foucar K., Feddersen R., Zumwalt R., Miller G., Rollin P., Ksiazek T., Nichol S., Peters C. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 1995, 146:552-579.
94. Zanetti A., Lampugnani M.G., Balconi G., Breviario F., Corada M., Lanfrancone L., Dejana E. Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Arterioscler. Thromb. Vasc. Biol. 2002, 22:617-622.
95. Zhou Q., Liu L.Z., Fu B., Hu X., Shi X., Fang J., Jiang B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 2007, 28:28-37.